Sangamo Therapeutics, Inc. (SGMO)
$0.07+0.00%Close
SELLCRISIS · day 12
Key stats
- Market cap
- $29M
- Beta
- 1.29
- P/E (TTM)
- -0.20
- 1W
- -58.82%
- 1M
- -58.82%
- vs SPY 1W
- -59.25%
- vs SPY 1M
- -60.88%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on SGMO?
- LOPJLB’s latest quantitative signal on Sangamo Therapeutics, Inc. (SGMO) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is SGMO in?
- Sangamo Therapeutics, Inc. (SGMO) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Sangamo Therapeutics, Inc. (SGMO) do?
- Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. The company's clinical-stage product candidates are ST-920, a gene therapy product candidate, which is in Phase 1/2 clinical study for the treatment of Fabry disease; small fib…